About Chesapeake Clinical Research, Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
2
Pfizer
2
Aimmune Therapeutics, Inc.
1
Allergy Therapeutics
1
Bayer
1
Bond Avillion 2 Development LP
1
Bosch Healthcare Solutions GmbH
1
Celldex Therapeutics
1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.
1
Optinose US Inc.
1
Regeneron Pharmaceuticals
1
Clinical Trials at Chesapeake Clinical Research, Inc
During the past decade, Chesapeake Clinical Research, Inc conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on
average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
2018-11-27
2022-01-19
Completed
332
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
2019-02-18
2020-04-08
Completed
287
Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
2019-08-20
2020-12-28
Terminated
15
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
2020-09-08
2021-04-13
Completed
122
Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough
2020-10-02
2021-07-23
Completed
310
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chesapeake Clinical Research, Inc" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Aimmune Therapeutics, Inc." with 1 trials sponsored, "Allergy Therapeutics" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chesapeake Clinical Research, Inc"
#1 collaborator was "Global BioClinical" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Chesapeake Clinical Research, Inc
According to Clinical.Site data, the most researched conditions in "Chesapeake Clinical Research, Inc" are
"Asthma" (3 trials), "Acute Respiratory Infection" (1 trials), "Asthma in Children" (1 trials), "Atopic Dermatitis" (1 trials) and "Chronic Rhinosinusitis" (1 trials). Many other conditions were trialed in "Chesapeake Clinical Research, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Chesapeake Clinical Research, Inc
Most popular intervention types in "Chesapeake Clinical Research, Inc" are "Drug" (10 trials), "Biological" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "AR201 powder" (1 trials), "AS MDI" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chesapeake Clinical Research, Inc
The vast majority of trials in "Chesapeake Clinical Research, Inc" are
13 trials for "All" genders.
Clinical Trials Status at Chesapeake Clinical Research, Inc
Currently, there are NaN active trials in "Chesapeake Clinical Research, Inc".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Chesapeake Clinical Research, Inc,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Chesapeake Clinical Research, Inc, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".